News and Updates September 2023Saros Therapeutics awarded Phase 2 SBIR from the National Cancer InstituteMore InformationPress Coverage May 2023Saros Therapeutics accepted to pitch at BIO’s selective Startup Stadium in Boston on June 6th between 11am and 1pmMore Information April 2023Moon Lab presenting key data from Saros’ STING program at 2023 annual ASCO meeting in ChicagoMore Information October 2022Frankel Award at the University of Michigan provides translational support for studies designed to validate mechanism of action in Saros’ STING programMore Information
